SeromYx at a glance:
- Formed in July 2019 to commercialize the Systems Serology platform developed by Dr. Galit Alter at the Ragon Institute of Harvard/MIT/MGH, with the support of DARPA and the Bill and Melinda Gates Foundation
- Our Mission: Use our proprietary tools to provide our clients with unprecedented insight into immune function so that they can discover and develop better vaccines, immunotherapies, drugs, and diagnostics
- Fee for service business model; no entanglement of client IP.
Learn about our ongoing work to support responses to the SARS-CoV-2 pandemic.